258 related articles for article (PubMed ID: 27492945)
21. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
[TBL] [Abstract][Full Text] [Related]
22. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
23. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
24. Catastrophic Intracranial Hemorrhages after IV tPA in a Patient with Insidious Onset of Fever and Back Pain.
Tversky S; Libman RB; Schloss ER; Arora R; Patel AV; Salamon EJ; Wright P; Katz JM
J Stroke Cerebrovasc Dis; 2016 May; 25(5):e69-e70. PubMed ID: 26806798
[TBL] [Abstract][Full Text] [Related]
25. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
[TBL] [Abstract][Full Text] [Related]
26. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature.
Tversky S; Libman RB; Reppucci ML; Tufano AM; Katz JM
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e167-70. PubMed ID: 27523596
[TBL] [Abstract][Full Text] [Related]
28. Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.
Fredwall M; Sternberg S; Blackhurst D; Lee A; Leacock R; Nathaniel TI
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2569-2574. PubMed ID: 27618196
[TBL] [Abstract][Full Text] [Related]
29. Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke.
Qureshi AI; Asif A; Aytac E; Liaqat J; Gurkas E; Lobanova I; Saeed O; Ahsan H; Siddiq F; Gomez CR; French BR
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104362. PubMed ID: 31562039
[TBL] [Abstract][Full Text] [Related]
30. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review.
Mannino M; Asciutto S; Terruso V; Gammino M; Cellura MG; Monaco S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e105-e107. PubMed ID: 28434774
[TBL] [Abstract][Full Text] [Related]
31. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
32. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
33. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
34. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke.
Chapman SN; Mehndiratta P; Johansen MC; McMurry TL; Johnston KC; Southerland AM
Vasc Health Risk Manag; 2014; 10():75-87. PubMed ID: 24591838
[TBL] [Abstract][Full Text] [Related]
35. Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.
Olindo S; Chardonnet M; Renou P; Coignion C; Debruxelles S; Poli M; Sagnier S; Rouanet F; Sibon I
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):454-459. PubMed ID: 29128327
[TBL] [Abstract][Full Text] [Related]
36. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
37. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
38. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
[TBL] [Abstract][Full Text] [Related]
39. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Cervicocephalic Dolichoarteriopathy.
Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2579-2586. PubMed ID: 28673809
[TBL] [Abstract][Full Text] [Related]
40. Intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
